RxDoctor Payments Data

Erika Surace

Family Medicine · New York, NYNPI 1053653931

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 110 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 11.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $574 and has fallen 77.6% since, to $129 in 2023.

$2,029in general payments, 2019–2025

Across 110 payments — averaging $18.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$234
  • Amneal Pharmaceuticals LLC$198
  • AstraZeneca$189
  • Astellas Pharma US Inc$177
  • Merck$162
  • GSK$131
  • plus $937 from 21 others

What the payments were for

  • Food & beverage$2,029100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,029 in reported general payments places this provider in the 75th percentile of 4,321 family medicine providers in New York.

See all family medicine providers in New York →

Other family medicine in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →